Dan Yamin

1.4k total citations
53 papers, 835 citations indexed

About

Dan Yamin is a scholar working on Epidemiology, Modeling and Simulation and Infectious Diseases. According to data from OpenAlex, Dan Yamin has authored 53 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 24 papers in Modeling and Simulation and 21 papers in Infectious Diseases. Recurrent topics in Dan Yamin's work include COVID-19 epidemiological studies (24 papers), Influenza Virus Research Studies (16 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). Dan Yamin is often cited by papers focused on COVID-19 epidemiological studies (24 papers), Influenza Virus Research Studies (16 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). Dan Yamin collaborates with scholars based in Israel, United States and United Kingdom. Dan Yamin's co-authors include Alison P. Galvani, Arieh Gavious, Matan Yechezkel, Shai Gertler, Mosoka Fallah, Laura Skrip, Martial L. Ndeffo-Mbah, Erez Shmueli, Tolbert Nyenswah and Frederick L. Altice and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Dan Yamin

50 papers receiving 811 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dan Yamin Israel	17	361	353	264	168	88	53	835
Laura Skrip United States	20	392 1.1×	291 0.8×	309 1.2×	102 0.6×	111 1.3×	61	1.1k
Caitlin Rivers United States	15	567 1.6×	494 1.4×	257 1.0×	94 0.6×	172 2.0×	31	1.2k
Akhona Tshangela United States	9	339 0.9×	276 0.8×	268 1.0×	182 1.1×	91 1.0×	17	823
Joel Kelso Australia	16	243 0.7×	507 1.4×	403 1.5×	71 0.4×	76 0.9×	25	882
Rebecca Kahn United States	18	523 1.4×	498 1.4×	204 0.8×	200 1.2×	32 0.4×	45	978
Jon Zelner United States	18	377 1.0×	174 0.5×	295 1.1×	114 0.7×	90 1.0×	64	928
Frederik Verelst Belgium	13	202 0.6×	394 1.1×	192 0.7×	227 1.4×	111 1.3×	26	797
Hani Jokhdar Saudi Arabia	16	286 0.8×	145 0.4×	133 0.5×	109 0.6×	54 0.6×	38	720
Britta L. Jewell United Kingdom	11	539 1.5×	339 1.0×	262 1.0×	66 0.4×	81 0.9×	14	911
Spencer J. Fox United States	14	236 0.7×	492 1.4×	303 1.1×	58 0.3×	42 0.5×	37	764

Countries citing papers authored by Dan Yamin

Since Specialization

Citations

This map shows the geographic impact of Dan Yamin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Yamin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Yamin more than expected).

Fields of papers citing papers by Dan Yamin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Yamin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Yamin. The network helps show where Dan Yamin may publish in the future.

Co-authorship network of co-authors of Dan Yamin

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Yamin. A scholar is included among the top collaborators of Dan Yamin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Yamin. Dan Yamin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yaron, Shlomit, et al.. (2025). Effectiveness of influenza vaccination in preventing severe COPD exacerbations and pneumonia before, during, and after the COVID-19 pandemic: a retrospective cohort study. The Lancet Regional Health - Europe. 53. 101307–101307.

Yamin, Dan, et al.. (2025). Anticipatory eye gaze as a marker of memory. Communications Psychology. 3(1). 122–122. 2 indexed citations

Ndeffo-Mbah, Martial L., et al.. (2025). Terminating pandemics with smartwatches. PNAS Nexus. 4(3). pgaf044–pgaf044.

Yaron, Shlomit, Matan Yechezkel, Dan Yamin, et al.. (2025). Incremental benefit of high dose compared to standard dose influenza vaccine in reducing hospitalizations. npj Vaccines. 10(1). 3–3. 3 indexed citations

Yechezkel, Matan, et al.. (2024). Comparison of physiological and clinical reactions to COVID-19 and influenza vaccination. SHILAP Revista de lepidopterología. 4(1). 169–169. 2 indexed citations

Chen, Yupeng, Matan Yechezkel, Tal Patalon, et al.. (2024). Changes in behavior and biomarkers during the diagnostic decision period for COVID-19, influenza, and group A streptococcus (GAS): a two-year prospective cohort study in Israel. The Lancet Regional Health - Europe. 42. 100934–100934. 2 indexed citations

Yechezkel, Matan, et al.. (2023). Real-time sensing of war’s effects on wellbeing with smartphones and smartwatches. SHILAP Revista de lepidopterología. 3(1). 55–55. 2 indexed citations

Yamin, Dan, Matan Yechezkel, Ronen Arbel, et al.. (2023). Safety of monovalent and bivalent BNT162b2 mRNA COVID-19 vaccine boosters in at-risk populations in Israel: a large-scale, retrospective, self-controlled case series study. The Lancet Infectious Diseases. 23(10). 1130–1142. 19 indexed citations

Yechezkel, Matan, Martial L. Ndeffo-Mbah, & Dan Yamin. (2021). Optimizing antiviral treatment for seasonal influenza in the USA: a mathematical modeling analysis. BMC Medicine. 19(1). 54–54. 9 indexed citations

10.

Yamin, Dan, et al.. (2021). Accounting for the spread of vaccination behavior to optimize influenza vaccination programs. PLoS ONE. 16(6). e0252510–e0252510. 6 indexed citations

11.

Yechezkel, Matan, et al.. (2021). Human mobility and poverty as key drivers of COVID-19 transmission and control. BMC Public Health. 21(1). 596–596. 41 indexed citations

12.

Yamin, Dan, et al.. (2021). Influenza vaccination should have no border: cost-effectiveness of cross-border subsidy. BMC Public Health. 21(1). 1543–1543. 2 indexed citations

13.

Ashlagi, Itai, et al.. (2020). Predicting and improving patient-level antibiotic adherence. Health Care Management Science. 23(4). 507–519. 9 indexed citations

14.

Chodick, Gabriel, et al.. (2020). Personal and social patterns predict influenza vaccination decision. BMC Public Health. 20(1). 222–222. 29 indexed citations

15.

Yamin, Dan, Katherine E. Atkins, Vanessa Rémy, & Alison P. Galvani. (2016). Cost-Effectiveness of Rotavirus Vaccination in France—Accounting for Indirect Protection. Value in Health. 19(6). 811–819. 8 indexed citations

16.

Wells, Chad R., Dan Yamin, Martial L. Ndeffo-Mbah, et al.. (2015). Harnessing Case Isolation and Ring Vaccination to Control Ebola. PLoS neglected tropical diseases. 9(5). e0003794–e0003794. 27 indexed citations

17.

Yamin, Dan, Ran D. Balicer, & Alison P. Galvani. (2014). Cost-effectiveness of influenza vaccination in prior pneumonia patients in Israel. Vaccine. 32(33). 4198–4205. 14 indexed citations

18.

Yamin, Dan, Arieh Gavious, Nadav Davidovitch, & Joseph S. Pliskin. (2014). Role of intervention programs to increase influenza vaccination in Israel. Israel Journal of Health Policy Research. 3(1). 13–13. 19 indexed citations

19.

Scarpino, Samuel V., Atila Iamarino, Chad R. Wells, et al.. (2014). Epidemiological and Viral Genomic Sequence Analysis of the 2014 Ebola Outbreak Reveals Clustered Transmission. Clinical Infectious Diseases. 60(7). 1079–1082. 41 indexed citations

20.

Yamin, Dan, et al.. (2013). Cardiac involvement in HIV-positive patients. GERMS. 3(1). 8–13. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact